Peer-reviewedCC BY-NC-NDKidney International Reports
Contrasting Evolution After Withdrawal of Long-Term Administration of Difelikefalin for CKD-Associated Pruritus
Abstract
Chronic kidney disease (CKD) associated pruritus (CKD-aP) is a very common condition in end-stage kidney disease under dialysis, affecting up to a third of the patients worldwide,1-2 with a significant impact of their quality of life.3 Until recently, therapeutic solutions were scarce and not very effective.4 The pathogenesis of CKD-aP is multifactorial, involving the accumulation of uremic toxins and inflammatory mediators, abnormal peripheral nerve conduction, and an imbalance between peripheral Mu opioid receptors (MORs) and Kappa opioid receptors (KORs).
Related
- Morphine causes distinct changes in the lipidome throughout the brain and body after acute or chronic administration: implications for novel endogenous lipid signaling systems involved in opioid reward and withdrawal
- PlantLRR-PRR:A Reproducible Annotation Pipeline Reveals Contrasting Evolution of Developmental and Defense Receptor-Like Proteins in Tomato
- Exploratory Proteomics of Brain Extracellular Vesicle Enriched Preparations After LPS Challenge and miRNA Associated Vesicle Administration
- Prepubertal NMN Administration is associated with changes in hippocampal neurogenesis-related markers and amelioration of cognitive deficits
- Acute withdrawal signatures are associated with delayed affective-like vulnerability after chronic intermittent ethanol exposure in rats
BibTeX
@article{rostoker2026contrasting,
title = {{Contrasting Evolution After Withdrawal of Long-Term Administration of Difelikefalin for CKD-Associated Pruritus}},
author = {Guy Rostoker and Antoine Lanot},
journal = {Kidney International Reports},
year = {2026},
month = sep,
doi = {10.1016/j.ekir.2024.01.019},
url = {https://hal.science/hal-05746191v1},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Contrasting Evolution After Withdrawal of Long-Term Administration of Difelikefalin for CKD-Associated Pruritus
AU - Guy Rostoker
AU - Antoine Lanot
PY - 2026
DA - 2026/09/11
JO - Kidney International Reports
DO - 10.1016/j.ekir.2024.01.019
UR - https://hal.science/hal-05746191v1
AB - Chronic kidney disease (CKD) associated pruritus (CKD-aP) is a very common condition in end-stage kidney disease under dialysis, affecting up to a third of the patients worldwide,1-2 with a significant impact of their quality of life.3 Until recently, therapeutic solutions were scarce and not very effective.4 The pathogenesis of CKD-aP is multifactorial, involving the accumulation of uremic toxins and inflammatory mediators, abnormal peripheral nerve conduction, and an imbalance between peripheral Mu opioid receptors (MORs) and Kappa opioid receptors (KORs).
SN - 2468-0249
ER -